Comera Life Sciences Inc... (CMRAW)
NASDAQ: CMRAW
· Real-Time Price · USD
0.02
null (null%)
At close: Sep 17, 2024, 10:00 PM
Comera Life Sciences Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.78 | -1.65 | -0.06 | -1.1 | -1.78 | -0.38 | -14.72 | -16.57 | -52.54 | -24.19 | -53.35 |
PEG Ratio | -0.02 | 0.02 | -0.00 | -0.05 | 0.02 | -0.00 | -1.1 | -0.08 | 1.01 | -0.21 | n/a |
PS Ratio | 49.43 | 29.61 | 43.55 | 82.35 | 109.82 | 146.50 | 2.04K | 1.83K | 2.19K | 2.7K | 1.3K |
PB Ratio | -1.6 | -1.47 | -3.25 | -2.06 | -7.53 | -11.99 | -11.39 | -9.13 | 1.95 | n/a | 749.34 |
P/FCF Ratio | -3.52 | -9.34 | -8.58 | -0.42 | -10.68 | -8.06 | -67.85 | -77.36 | -203.15 | -262.55 | -231.95 |
P/OCF Ratio | -3.52 | -9.39 | -8.98 | -6.96 | -10.8 | -8.07 | -67.85 | -83.65 | -205.65 | -262.55 | -231.95 |
OCF/S Ratio | -14.04 | -3.15 | -4.85 | -11.84 | -10.17 | -18.16 | -30.1 | -21.87 | -10.64 | -10.29 | -5.59 |
Debt / Equity Ratio | -0.04 | -0.13 | -0.05 | -0.12 | -0.37 | -0.23 | -0.02 | -0.02 | n/a | n/a | n/a |
Quick Ratio | 0.90 | 0.20 | 0.56 | 0.11 | 0.88 | 2.03 | 3.91 | 6.49 | 402.07 | n/a | n/a |
Current Ratio | 0.90 | 0.46 | 0.72 | 0.61 | 1.25 | 2.14 | 4.26 | 6.49 | 402.07 | n/a | n/a |
Asset Turnover | 0.04 | 0.13 | 0.13 | 0.04 | 0.05 | 0.02 | 0.02 | 0.01 | 0.00 | n/a | n/a |
Interest Coverage | -361.62 | -372.2 | -328.23 | -395 | -199.7 | -0.78 | -31.85K | n/a | n/a | n/a | n/a |
Return on Equity | 0.51 | 0.22 | 14.77 | 0.47 | 1.06 | 7.92 | 0.19 | 0.14 | -0.01 | n/a | -3.51 |
Return on Assets | -0.7 | -0.6 | -25.93 | -0.78 | -0.73 | -2.32 | -0.67 | -0.27 | -0.01 | n/a | n/a |
Return on Invested Capital | -6.93 | 1.84 | 566.25 | 4.38 | -1.14 | -1.63 | -0.69 | -0.3 | -0.04 | n/a | -4.46 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.69 | 0.82 | 0.70 | 0.68 | 0.74 | 0.63 | 0.53 | 0.47 | 0.45 | 0.19 | 0.82 |
Net Profit Margin | -15.8 | -4.48 | -197.93 | -18.68 | -15.4 | -96.76 | -34.68 | -27.6 | -10.41 | -27.93 | -6.07 |
Pretax Profit Margin | -15.8 | -4.48 | -6.32 | -18.98 | -13.1 | -61.92 | -30.2 | -27.6 | -10.41 | -27.93 | -6.07 |
Operating Profit Margin | -15.82 | -4.7 | -6.36 | -19.27 | -10.79 | -27.08 | -25.73 | -27.6 | -10.41 | -26.85 | -7.9 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -15.58 | -4.38 | -6.22 | -18.78 | -12.94 | -61.92 | -25.47 | -27.27 | -10.19 | -27.93 | 48.37 |